Cities Bet on Biotech | GenomeWeb

Cities Bet on Biotech

States are spending a lot of money to woo biotech companies to their cities, despite the long odds, says the New York Times. The North Carolina Research Campus, also called the Biopolis, cost $500 million; Florida, particularly Palm Beach County, has spent $510 million to entice research institutes to head there (and Scripps and Torrey Pines did); and New York City is putting $45 million into science infrastructure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.